Market Development Manager - Dallas

HISTOSONICS INC• TX, US, TX

7h•$0 - $100,000•Hybrid

About The Position

HistoSonics is a commercial-stage medtech company advancing the Edison® System, a novel non-invasive sonic beam therapy based on histotripsy. Since receiving FDA De Novo grant for the non-invasive destruction of liver tumors in 2023, the company has progressed beyond initial market entry into commercial expansion, reimbursement momentum, and ongoing clinical and pipeline development. In addition to its current liver tumor indication, HistoSonics is pursuing future indications across multiple applications including kidney, pancreas, prostate, neuro, women’s health, and other significant underserved human health areas, to realize the broader potential histotripsy across multiple disease states and medical specialties. We offer an exciting work culture where cutting-edge science meets real-world application, and each team member’s contribution is important to our success in ensuring our physicians and their patients get what they need most.

Requirements

Bachelor's degree in Business, Life Sciences, or a Healthcare-related field.
Minimum of 2 years of sales or clinical liaison experience, preferably in medical device, capital equipment, or interventional/surgical oncology settings, with a track record of meeting individual pipeline development or sales quotas.
Demonstrated success prospecting and building relationships with physician and hospital administrative stakeholders.
Must be able to meet all hospital credentialing requirements, including but not limited to background check, drug screen, and certain immunizations.
Must be insurable and maintain a valid driver's license.
Must be willing and able to travel (by automobile or air, day trips and overnight stays) up to 75% of the time.
Results/action oriented with a drive to achieve and compete.
Curious, driven to achieve, and willing to ask thoughtful questions.
Excellent verbal and written communication skills.
Ability to work independently, with minimal supervision, as well as collaboratively with ASMs, the ASD, AMs, and cross-functional teams.
Strong organizational and time management skills, including the ability to prioritize a busy prospecting schedule across multiple ASM territories.
Strong customer service skills.
Exceptional personal initiative and desire to drive continuous improvement.

Nice To Haves

Working knowledge of interventional radiology, hepatobiliary surgery, or oncology capital equipment sales processes a plus.

Responsibilities

Map and prioritize target accounts within the region based on liver tumor case volume, interventional radiology/hepatobiliary surgery/surgical oncology program maturity, and capital equipment readiness.
Build early relationships with interventional radiologists, hepatobiliary and surgical oncologists, tumor board leaders, and hospital administrators to introduce histotripsy and the Edison System ahead of formal ASM engagement.
Conduct discovery conversations to understand each account's clinical workflows, capital acquisition process, and decision-making structure.
Partner with assigned ASMs to prioritize the highest-potential accounts, share complete stakeholder and clinical context, and jointly track deal progression from lead to qualified opportunity.
Maintain a live, accurate pipeline and territory plan for each supported ASM, and report pipeline health and prospecting metrics to the ASD on a regular cadence.
Coordinate with Account Managers (AMs) on newly closed accounts to ensure a smooth handoff into program launch, physician training, and utilization growth.
Help identify potential key opinion leaders (KOLs) and centers of excellence for future reference sites and speaker development, feeding candidates to the AM team.
Support trade shows, regional conferences, and other business development and educational activities to build the region's referral network.
Develop and maintain working clinical, technical, and business knowledge of histotripsy and the Edison System to speak credibly with prospective customers.
Comply with all regulatory and AdvaMed guidelines for pre- and post-commercialization activities.